Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Potent PAI-1 inhibitors discovered by ADIR scientists

May 25, 2001

GlycoDesign and Leo select antithrombotic drug candidates

May 22, 2001

Adhesion receptor antagonists reported by Merck as useful in thrombotic disorders

May 22, 2001

ConjuChem completes phase I trial of anticlotting compound

May 17, 2001

Carafiban maleate, an orally active fibrinogen antagonist with clinical potential

May 17, 2001

Meiji Seika's new phosphonic acid derivatives particularly useful in thrombotic disorders

May 16, 2001

Cor patents new series of factor Xa inhibitors with high potency and selectivity

May 16, 2001

Bivalent FVIIa/TF/FXa complex inhibitors

May 15, 2001

UR-3216 emerges as a promising new gpIIb/IIIa antagonist for cardiovascular disorders

May 14, 2001

Direct thrombin inhibitor LB-30057 compared with inogatran in rabbit thrombosis model

May 11, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...